

HY-139140 · 50 mg
MedChemExpress · Cat: HY-139140
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bay-r3401.htmlDescription
BAY R3401 is an orally active glycogen phosphorylase inhibitor that can achieve irreversible and non-selective inhibition of hepatic glycogenolysis. BAY R3401 inhibits glycogenolysis in liver cells, with IC50 values of 27.06 and 52.83 ?M in HL-7702 and HepG2 cells, respectively. BAY R3401 can be used for the research of type 2 diabetes.







